Neuronetics Inc Sustainability Reports
Neuronetics, Inc. is a medical technology company focused on developing and commercializing non-invasive treatments for chronic psychiatric and neurological disorders. The company's primary product is the NeuroStar Advanced Therapy system, which utilizes transcranial magnetic stimulation (TMS) to treat major depressive disorder.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300T0911ILTTG7P06
FIGI: BBG001SSSWY7
1 reports from 2020 to 2020
